← Leaderboards
Tejvir S Khurana
University Of Pennsylvania
$7,406,200
Attributed
$8,441,535
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $959.8K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,441,535 · 9
By mechanism
R01$4,923,490 · 2
R33$1,457,611 · 2
R21$994,125 · 3
R61$575,548 · 1
UG3$490,761 · 1
Top collaborators
- Joseph A. Baur3 shared
- Donna M Huryn3 shared
- Samuel T Lamitina2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Joseph A. Baur$17,043,751
- Jon Martin Lindstrom$10,344,333
- Neal A Rubinstein$1,719,915
- Arnold I Levinson$2,286,603
- Amy J. Gleichman$283,558
Others in their field
Top investigators on “Muscle”
- Kenton M Sanders · University Of Nevada Reno$54,512,961
- Lynn A Sleeper · New England Research Institutes, Inc.$48,671,277
- Clifford B Saper · Harvard University (Medical School)$38,171,545
- Charles P Emerson · University Of Pennsylvania$37,572,397
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$36,830,932
- Mary McGrae McDermott · Northwestern University$36,469,369
Research focus
MuscleBaseResponseMutationAffectPhenotypeGenesDystrophinBiologyCellsToxic EffectMuscle CellsDoseIn VitroBiochemicalNeuromuscular JunctionUtrophinMolecularPlayProteinsHomologous GeneMediatingUntranslated RegionsValidation
Grant awards (25)
Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)$490,761
UG3 · FY2023 · NS · contact PI
HTS to identify compounds that increase NAD+ levels in neurons and muscle cells$373,195
R33 · FY2023 · NS · contact PI
HTS to identify compounds that increase NAD+ levels in neurons and muscle cells$279,416
R33 · FY2022 · NS · contact PI
HTS to identify compounds that increase NAD+ levels in neurons and muscle cells$575,548
R61 · FY2020 · NS · contact PI
Discovery of Post-transcriptional utrophin upregulator small molecules for Duchenne Muscular Dystrophy therapeutics$402,500
R33 · FY2019 · NS · contact PI
Discovery of Post-transcriptional utrophin upregulator small molecules for Duchenne Muscular Dystrophy therapeutics$402,500
R33 · FY2018 · NS · contact PI
Discovery of Post-transcriptional utrophin upregulator small molecules for Duchenne Muscular Dystrophy therapeutics$402,500
R21 · FY2017 · NS · contact PI
Molecular Characterization of Extraocular Muscle (EOM)$412,002
R01 · FY2010 · EY · contact PI
Preclinical Development of a Novel Therapeutic Strategy for LGMD2B$157,500
R21 · FY2010 · NS · contact PI
Molecular Characterization of Extraocular Muscle (EOM)$397,500
R01 · FY2009 · EY · contact PI
Regulation of Utrophin Promoter in Muscle$286,646
R01 · FY2009 · AR · contact PI
Preclinical Development of a Novel Therapeutic Strategy for LGMD2B$275,625
R21 · FY2009 · NS · contact PI
Molecular Characterization of Extraocular Muscle$377,076
R01 · FY2008 · EY · contact PI
Regulation of Utrophin Promoter in Muscle$286,646
R01 · FY2008 · AR · contact PI
Molecular Characterization of Extraocular Muscle$384,771
R01 · FY2007 · EY · contact PI
Regulation of Utrophin Promoter in Muscle$292,496
R01 · FY2007 · AR · contact PI
Molecular Characterization of Extraocular Muscle$386,938
R01 · FY2006 · EY · contact PI
Regulation of Utrophin Promoter in Muscle$301,231
R01 · FY2006 · AR · contact PI
Molecular Characterization of Extraocular Muscle$396,250
R01 · FY2005 · EY
Regulation of Utrophin Promoter in Muscle$335,228
R01 · FY2005 · AR
Extraocular muscle stem cells for DMD therapy$79,250
R21 · FY2005 · AR
Molecular Characterization of Extraocular Muscle$396,250
R01 · FY2004 · EY
Regulation of Utrophin Promoter in Muscle$335,228
R01 · FY2004 · AR
Extraocular muscle stem cells for DMD therapy$79,250
R21 · FY2004 · AR
Regulation of Utrophin Promoter in Muscle$335,228
R01 · FY2003 · AR